nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—Cardiac arrest—Vandetanib—thyroid cancer	0.0524	0.0524	CcSEcCtD
Sufentanil—Bronchospasm—Vandetanib—thyroid cancer	0.0468	0.0468	CcSEcCtD
Sufentanil—Bradycardia—Vandetanib—thyroid cancer	0.0388	0.0388	CcSEcCtD
Sufentanil—Urinary tract disorder—Vandetanib—thyroid cancer	0.0376	0.0376	CcSEcCtD
Sufentanil—Urethral disorder—Vandetanib—thyroid cancer	0.0374	0.0374	CcSEcCtD
Sufentanil—Arrhythmia—Vandetanib—thyroid cancer	0.034	0.034	CcSEcCtD
Sufentanil—Hypertension—Vandetanib—thyroid cancer	0.0286	0.0286	CcSEcCtD
Sufentanil—Urinary tract disorder—Sorafenib—thyroid cancer	0.0254	0.0254	CcSEcCtD
Sufentanil—Urethral disorder—Sorafenib—thyroid cancer	0.0252	0.0252	CcSEcCtD
Sufentanil—Injection site pain—Epirubicin—thyroid cancer	0.0232	0.0232	CcSEcCtD
Sufentanil—Arrhythmia—Sorafenib—thyroid cancer	0.023	0.023	CcSEcCtD
Sufentanil—Erythema—Sorafenib—thyroid cancer	0.0224	0.0224	CcSEcCtD
Sufentanil—Injection site pain—Doxorubicin—thyroid cancer	0.0214	0.0214	CcSEcCtD
Sufentanil—Body temperature increased—Vandetanib—thyroid cancer	0.0214	0.0214	CcSEcCtD
Sufentanil—Hypertension—Sorafenib—thyroid cancer	0.0193	0.0193	CcSEcCtD
Sufentanil—Pruritus—Vandetanib—thyroid cancer	0.0192	0.0192	CcSEcCtD
Sufentanil—Anaphylactic shock—Sorafenib—thyroid cancer	0.0183	0.0183	CcSEcCtD
Sufentanil—Dizziness—Vandetanib—thyroid cancer	0.0179	0.0179	CcSEcCtD
Sufentanil—Vomiting—Vandetanib—thyroid cancer	0.0172	0.0172	CcSEcCtD
Sufentanil—Rash—Vandetanib—thyroid cancer	0.0171	0.0171	CcSEcCtD
Sufentanil—Dermatitis—Vandetanib—thyroid cancer	0.0171	0.0171	CcSEcCtD
Sufentanil—Headache—Vandetanib—thyroid cancer	0.017	0.017	CcSEcCtD
Sufentanil—Nausea—Vandetanib—thyroid cancer	0.0161	0.0161	CcSEcCtD
Sufentanil—Body temperature increased—Sorafenib—thyroid cancer	0.0144	0.0144	CcSEcCtD
Sufentanil—Hypersensitivity—Sorafenib—thyroid cancer	0.0135	0.0135	CcSEcCtD
Sufentanil—Cardiac arrest—Epirubicin—thyroid cancer	0.0131	0.0131	CcSEcCtD
Sufentanil—Pruritus—Sorafenib—thyroid cancer	0.0129	0.0129	CcSEcCtD
Sufentanil—Cardiac arrest—Doxorubicin—thyroid cancer	0.0121	0.0121	CcSEcCtD
Sufentanil—Dizziness—Sorafenib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Sufentanil—Vomiting—Sorafenib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Sufentanil—Rash—Sorafenib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Sufentanil—Dermatitis—Sorafenib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Sufentanil—Headache—Sorafenib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Sufentanil—Nausea—Sorafenib—thyroid cancer	0.0108	0.0108	CcSEcCtD
Sufentanil—Bradycardia—Epirubicin—thyroid cancer	0.00967	0.00967	CcSEcCtD
Sufentanil—Urinary tract disorder—Epirubicin—thyroid cancer	0.00938	0.00938	CcSEcCtD
Sufentanil—Urethral disorder—Epirubicin—thyroid cancer	0.00931	0.00931	CcSEcCtD
Sufentanil—Bradycardia—Doxorubicin—thyroid cancer	0.00895	0.00895	CcSEcCtD
Sufentanil—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00868	0.00868	CcSEcCtD
Sufentanil—Urethral disorder—Doxorubicin—thyroid cancer	0.00862	0.00862	CcSEcCtD
Sufentanil—Chills—Epirubicin—thyroid cancer	0.00852	0.00852	CcSEcCtD
Sufentanil—Arrhythmia—Epirubicin—thyroid cancer	0.00849	0.00849	CcSEcCtD
Sufentanil—Erythema—Epirubicin—thyroid cancer	0.00827	0.00827	CcSEcCtD
Sufentanil—Chills—Doxorubicin—thyroid cancer	0.00789	0.00789	CcSEcCtD
Sufentanil—Arrhythmia—Doxorubicin—thyroid cancer	0.00785	0.00785	CcSEcCtD
Sufentanil—Erythema—Doxorubicin—thyroid cancer	0.00765	0.00765	CcSEcCtD
Sufentanil—Hypertension—Epirubicin—thyroid cancer	0.00714	0.00714	CcSEcCtD
Sufentanil—Confusional state—Epirubicin—thyroid cancer	0.00681	0.00681	CcSEcCtD
Sufentanil—Anaphylactic shock—Epirubicin—thyroid cancer	0.00675	0.00675	CcSEcCtD
Sufentanil—Hypertension—Doxorubicin—thyroid cancer	0.00661	0.00661	CcSEcCtD
Sufentanil—Tachycardia—Epirubicin—thyroid cancer	0.00659	0.00659	CcSEcCtD
Sufentanil—Hypotension—Epirubicin—thyroid cancer	0.00631	0.00631	CcSEcCtD
Sufentanil—Confusional state—Doxorubicin—thyroid cancer	0.0063	0.0063	CcSEcCtD
Sufentanil—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00625	0.00625	CcSEcCtD
Sufentanil—Tachycardia—Doxorubicin—thyroid cancer	0.00609	0.00609	CcSEcCtD
Sufentanil—Somnolence—Epirubicin—thyroid cancer	0.006	0.006	CcSEcCtD
Sufentanil—Hypotension—Doxorubicin—thyroid cancer	0.00584	0.00584	CcSEcCtD
Sufentanil—Feeling abnormal—Epirubicin—thyroid cancer	0.00556	0.00556	CcSEcCtD
Sufentanil—Somnolence—Doxorubicin—thyroid cancer	0.00555	0.00555	CcSEcCtD
Sufentanil—Body temperature increased—Epirubicin—thyroid cancer	0.00534	0.00534	CcSEcCtD
Sufentanil—Feeling abnormal—Doxorubicin—thyroid cancer	0.00515	0.00515	CcSEcCtD
Sufentanil—Hypersensitivity—Epirubicin—thyroid cancer	0.00497	0.00497	CcSEcCtD
Sufentanil—Body temperature increased—Doxorubicin—thyroid cancer	0.00494	0.00494	CcSEcCtD
Sufentanil—Pruritus—Epirubicin—thyroid cancer	0.00478	0.00478	CcSEcCtD
Sufentanil—Hypersensitivity—Doxorubicin—thyroid cancer	0.0046	0.0046	CcSEcCtD
Sufentanil—Dizziness—Epirubicin—thyroid cancer	0.00446	0.00446	CcSEcCtD
Sufentanil—Pruritus—Doxorubicin—thyroid cancer	0.00442	0.00442	CcSEcCtD
Sufentanil—Vomiting—Epirubicin—thyroid cancer	0.00429	0.00429	CcSEcCtD
Sufentanil—Rash—Epirubicin—thyroid cancer	0.00426	0.00426	CcSEcCtD
Sufentanil—Dermatitis—Epirubicin—thyroid cancer	0.00425	0.00425	CcSEcCtD
Sufentanil—Headache—Epirubicin—thyroid cancer	0.00423	0.00423	CcSEcCtD
Sufentanil—Dizziness—Doxorubicin—thyroid cancer	0.00413	0.00413	CcSEcCtD
Sufentanil—Nausea—Epirubicin—thyroid cancer	0.00401	0.00401	CcSEcCtD
Sufentanil—Vomiting—Doxorubicin—thyroid cancer	0.00397	0.00397	CcSEcCtD
Sufentanil—Rash—Doxorubicin—thyroid cancer	0.00394	0.00394	CcSEcCtD
Sufentanil—Dermatitis—Doxorubicin—thyroid cancer	0.00393	0.00393	CcSEcCtD
Sufentanil—Headache—Doxorubicin—thyroid cancer	0.00391	0.00391	CcSEcCtD
Sufentanil—Nausea—Doxorubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
